Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies

Travellers and influenza: risks and prevention

(2017) M. Goeijenbier et al.   JOURNAL OF TRAVEL MEDICINE

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

(2017) Lisa M. Dunkle et al.   NEW ENGLAND JOURNAL OF MEDICINE

The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial

(2017) Barnaby Young et al.   Trials

Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis

(2017) Krista Wilkinson et al.   VACCINE

Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis

(2017) Barnaby Young et al.   VACCINE

Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection

(2017) R G Pebody et al.   Eurosurveillance

Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study

(2017) E Kissling et al.   Eurosurveillance

Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12

(2017) J Castilla et al.   Eurosurveillance

Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007–2008 Influenza Season

(2016) Joshua G. Petrie et al.   JOURNAL OF INFECTIOUS DISEASES

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

(2016) Jiwon Lee et al.   NATURE MEDICINE

Uptake and Effectiveness of a Trivalent Inactivated Influenza Vaccine in Children in Urban and Rural Kenya, 2010 to 2012

(2016) Mark A. Katz et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014–15

(2016) Alin Gherasim et al.   VACCINE

A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization

(2016) Justin R. Ortiz et al.   VACCINE

Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010–2011 through 2013–2014

(2016) Jennifer M. Radin et al.   VACCINE

Influenza Seasonality in the Tropics and Subtropics – When to Vaccinate?

(2016) Siddhivinayak Hirve et al.   PLoS One

Global circulation patterns of seasonal influenza viruses vary with antigenic drift

(2015) Trevor Bedford et al.   NATURE

Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season

(2015) Edward A. Belongia et al.   VACCINE

Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease

(2015) Robert G. Deiss et al.   VACCINE

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Influenza Vaccine Effectiveness in the Tropics: Moderate Protection in a Case Test-Negative Analysis of a Hospital-Based Surveillance Population in Bangkok between August 2009 and January 2013

(2015) Jens W. Levy et al.   PLoS One

Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results

(2014) N Andrews et al.   Eurosurveillance

Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies

(2014) Maryam Darvishian et al.   LANCET INFECTIOUS DISEASES

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

(2014) Carlos A. DiazGranados et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination

(2013) Silvia Jiménez-Jorge et al.   BMC INFECTIOUS DISEASES

The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials

(2013) G De Serres et al.   Eurosurveillance

Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match

(2013) Sheena G. Sullivan et al.   JOURNAL OF MEDICAL VIROLOGY

The case test-negative design for studies of the effectiveness of influenza vaccine

(2013) Ivo M. Foppa et al.   VACCINE

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

(2012) Laurent Coudeville et al.   BMC Medical Research Methodology

Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine

(2012) Benjamin J. Cowling et al.   CLINICAL INFECTIOUS DISEASES

Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence

(2010) Joon Young Song et al.   VACCINE

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal